The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how electronic components stocks fared in Q2, starting with Advanced Energy (NASDAQ:AEIS).
Like many equipment and component manufacturers, electronic components companies are buoyed by secular trends such as connectivity and industrial automation. More specific pockets of strong demand include data centers and telecommunications, which can benefit companies whose optical and transceiver offerings fit those markets. But like the broader industrials sector, these companies are also at the whim of economic cycles. Consumer spending, for example, can greatly impact these companies’ volumes.
The 8 electronic components stocks we track reported an exceptional Q2. As a group, revenues beat analysts’ consensus estimates by 3.3% while next quarter’s revenue guidance was 6.9% above.
Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 7.2% since the latest earnings results.
Advanced Energy (NASDAQ:AEIS)
Pioneering technologies for radio frequency power delivery, Advanced Energy (NASDAQ:AEIS) provides power supplies, thermal management systems, and measurement and control instruments for various manufacturing processes.
Advanced Energy reported revenues of $574.1 million, up 30% year on year. This print exceeded analysts’ expectations by 5.6%. Overall, it was an incredible quarter for the company with EPS guidance for next quarter exceeding analysts’ expectations and an impressive beat of analysts’ adjusted operating income estimates.
Advanced Energy achieved the biggest analyst estimate beat of the whole group. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 10% since reporting and currently trades at $266.82.
Best Q2: Allient (NASDAQ:ALNT)
Founded in 1962, Allient (NASDAQ:ALNT) develops and manufactures precision and specialty-controlled motion components and systems.
Allient reported revenues of $153.8 million, up 10.2% year on year, outperforming analysts’ expectations by 5.5%. The business had an incredible quarter with a beat of analysts’ EPS and EBITDA estimates.
Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 7.1% since reporting. It currently trades at $86.66.
Is now the time to buy Allient? Access our full analysis of the earnings results here, it’s free.
Weakest Q2: nLIGHT (NASDAQ:LASR)
Founded by a former CEO and Harvard-educated entrepreneur Scott Keeneyn, nLIGHT (NASDAQ:LASR) offers semiconductor and fiber lasers to the industrial, aerospace & defense, and medical sectors.
nLIGHT reported revenues of $82.59 million, up 33.8% year on year, exceeding analysts’ expectations by 4.6%. It was a satisfactory quarter as it also posted EPS in line with analysts’ estimates but EBITDA guidance for next quarter missing analysts’ expectations significantly.
As expected, the stock is down 46.4% since the results and currently trades at $40.43.
Read our full analysis of nLIGHT’s results here.
Littelfuse (NASDAQ:LFUS)
The developer of the first blade-type automotive fuse, Littelfuse (NASDAQ:LFUS) provides electrical protection and control components for the automotive, industrial, electronics, and telecommunications industries.
Littelfuse reported revenues of $738.8 million, up 20.4% year on year. This number surpassed analysts’ expectations by 5.4%. It was a stunning quarter as it also produced an impressive beat of analysts’ EBITDA and EPS estimates.
The stock is up 4.4% since reporting and currently trades at $409.33.
Read our full, actionable report on Littelfuse here, it’s free.
Novanta (NASDAQ:NOVT)
Originally a pioneer in the laser scanning industry during the late 1960s, Novanta (NASDAQ:NOVT) offers medicine and manufacturing technology to the medical, life sciences, and manufacturing industries.
Novanta reported revenues of $265.8 million, up 10.3% year on year. This print topped analysts’ expectations by 1.3%. Overall, it was an exceptional quarter as it also recorded EBITDA guidance for next quarter exceeding analysts’ expectations and revenue guidance for next quarter exceeding analysts’ expectations.
Novanta pulled off the highest guidance raise among its peers. The stock is down 9.2% since reporting and currently trades at $139.10.
Read our full, actionable report on Novanta here, it’s free.
Market Update
Over the past year, investors have been forced to repeatedly answer the same question: what is the market’s biggest risk? The answer has changed several times, and each shift has reshaped market leadership.
Late in 2025 and early 2026, artificial intelligence became the market’s primary uncertainty. Investors questioned whether AI would erode software pricing power and weaken competitive moats as AI made it easier to replicate once-differentiated products.
By the spring, technology took a back seat to geopolitics. The U.S. conflict with Iran briefly became the market’s dominant narrative, raising concerns about oil prices, inflation, and global growth. But as energy markets remained orderly and fears of a prolonged supply disruption faded, investors quickly turned their focus back to fundamentals.
Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.